Microbix Biosystems (TSE:MBX) Shares Cross Above 50 Day Moving Average – Here’s What Happened

Microbix Biosystems Inc. (TSE:MBX) passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.23 and traded as high as C$0.26. Microbix Biosystems shares last traded at C$0.23, with a volume of 106,000 shares.

Microbix Biosystems Stock Down 4.2%

The firm has a market cap of C$31.87 million, a price-to-earnings ratio of -7.67 and a beta of 0.40. The stock has a 50-day moving average of C$0.23 and a 200-day moving average of C$0.24. The company has a current ratio of 7.51, a quick ratio of 5.57 and a debt-to-equity ratio of 30.47.

Microbix Biosystems (TSE:MBX) last issued its earnings results on Thursday, February 12th. The company reported C($0.01) earnings per share for the quarter. The company had revenue of C$4.22 million during the quarter. Microbix Biosystems had a negative return on equity of 14.88% and a negative net margin of 25.48%. As a group, sell-side analysts forecast that Microbix Biosystems Inc. will post 0.02 EPS for the current fiscal year.

Microbix Biosystems Company Profile

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.